AbbVie Inc. ABBV NYSE

AbbVie Inc. (ABBV) generated $5.22B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $329M, free cash flow was $4.89B.

Free cash flow margin was 29.4% of revenue. Cash conversion ratio was 2.87x, indicating earnings are backed by cash.

The company returned $2.91B in dividends and $3M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (94/100, Pass) — $4.89B (29.4% margin) supports a durable competitive advantage
• INCOME (45/100) — Cash conversion ratio was 2.87x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 61/100 with 3/7 criteria passed.